Publicacións nas que colabora con José Luis Zamorano Gómez (30)

2022

  1. Challenges in managing patients with heart failure with reduced ejection fraction

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 1-7

  2. Role of vericiguat in the overall etiopathogenesis of heart failure with reduced ejection fraction. Current position

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 8-14

  3. Therapeutic approach to patients with heart failure with reduced ejection fraction. The role of vericiguat

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 23-29

  4. Vericiguat in heart failure: from scientific evidence to clinical practice

    Revista Clinica Espanola

  5. Vericiguat: VICTORIA trial results

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 15-22

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

  2. Evolocumab and clinical outcomes in patients with cardiovascular disease

    New England Journal of Medicine, Vol. 376, Núm. 18, pp. 1713-1722

2015

  1. 2014 ESC/ESA guidelines on non-cardiac surgery: Cardiovascular assessment and management

    Russian Journal of Cardiology, Vol. 124, Núm. 8, pp. 7-66